18915 (2026). Hon Dr Ayesha Verrall to the Associate Minister of Health

Written Question

Published date: 24 May 2026

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	18915 (2026)
Question asked:	10 May 2026
Member asking:	Hon Dr Ayesha Verrall
Portfolio:	Associate Minister of Health
Minister replying:	Hon David Seymour
Answer received:	19 May 2026
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_18915_2026
Document guid:	13e3402a-2d78-423e-9c1f-95a617d9d029

18915 (2026). Hon Dr Ayesha Verrall to the Associate Minister of Health: Has asciminib been funded by Pharmac for the treatment of chronic phase Philadelphia chromosome positive (or BCR-ABL1 transcript positive without T315I mutation) chronic myeloid leukaemia in patients previously treated with two or more tyrosine kinase inhibitors, if not, is it under consideration for funding?

Hon David Seymour: I am advised by Pharmac that an application for asciminib for this indication has been received and is currently under assessment. I refer the Member to the following link for more information: https://connect.pharmac.govt.nz/apptracker/s/application-public/a10OZ000000szzN/p002030